| DAIC

October 12, 2023 — Franklin Mountain Medical announced today that the Dib UltraNav Transseptal Catheter System, which houses a needle and ultrasound in one system for use in atrial transseptal procedures and delivery of catheters, has now been successfully used in 15 human cases, at major cardiology hospitals in Arizona and Minnesota.

Read more about UltraNav System Enables Safer and More Cost-Effective Transseptal Procedures by Aligning Catheter and Ultrasound

October 12, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease, today announces completion of enrollment in its

Read more about BioCardia Announces Completion of Enrollment in Phase III CardiAMP HF Trial and Plans for CardiAMP HF Trial II

October 11, 2023 — Unvaccinated people who have recovered from COVID-19 are at heightened risk of heart complications almost a year later, a national study led by Nanyang Technological University, Singapore (NTU Singapore) and affiliated faculty has found.

Read more about Unvaccinated Covid-19 Survivors Face Higher Risk of Heart Complications, Singapore Study Finds

October 11, 2023 — Tenaya Therapeutics, Inc., a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today released new data for TN-301 at the 2023 Heart Failure Society of America (HFSA) Annual Scientific Meeting.

Read more about Tenaya Therapeutics Presents Encouraging New Clinical and Preclinical Data from HDAC6 Inhibitor Program TN-301 for the Potential Treatment of Heart Failure with Preserved Ejection Fraction at the 2023 HFSA Annual Scientific Meeting

October 11, 2023 — Realizing a vision to deliver the best care to patients close to where they live in northern Ohio, GE HealthCare and University Hospitals (UH) announced a 10-year strategic collaboration to bring GE HealthCare technologies to UH across its radiology practice and UH Harrington Heart & Vascular Institute, providing contemporary equipment and

Read more about GE HealthCare and University Hospitals Enter 10-Year Strategic Collaboration to Contemporize Its Imaging Fleet and Implement Enterprise Digital Solutions to Help Improve Patient Care and Optimize Processes

October 11, 2023 — A newly-issued American Heart Association presidential advisory identifies the strong connections among cardiovascular disease (CVD), kidney disease, Type 2 diabetes and obesity, and suggests redefining CVD risk, prevention and management.

Read more about American Heart Association Presidential Advisory defines cardiovascular-kidney-metabolic (CKM) syndrome for first time

October 11, 2023 — To gain the latest insight into genetic research for the treatment of hypertrophic cardiomyopathy, DAIC's Managing Editor conducted an in-depth interview with

Read more about “One on One” with Christine Seidman, MD, FACC, on Hypertrophic Cardiomyopathy
Log in or register to post comments

October 10, 2023 — Axon Therapies, a private company focused on addressing a root cause of heart failure, announced 6-month results of the REBALAN

Read more about Late-Breaking Data Confirms Safety of Axon Therapies' Innovative Heart Failure Procedure and Identifies Patients Most Likely to Benefit from SAVM Therapy

October 10, 2023 — Hawthorne Effect, a complete clinical trials solution, announced interi

Read more about Hawthorne Effect Announces Monumental Diversity in Patient Recruitment Data for Valvular Heart Disease Study

October 10, 2023 — Elixir Medical, a developer of innovative cardiovascular technologies, announced it will present primary endpoint and 6-month data from its DESyne BDS Plus Randomized Clinical Trial (RCT), a prospec

Read more about Elixir Medical To Present Randomized Clinical Dataset Featuring World’s First Triple Drug-Eluting Coronary Implant Eluting Two Anticoagulants and Sirolimus at TCT 2023

Subscribe to

If you enjoy this content, please share it with a colleague